Tumor Regression Grading of Gastrointestinal Carcinomas after Neoadjuvant Treatment

Por Thies, Svenja, Langer, Rupert
Publicado em 2013

Tumor Budding in Upper Gastrointestinal Carcinomas

Por Koelzer, Viktor H., Langer, Rupert, Zlobec, Inti, Lugli, Alessandro
Publicado em 2014

Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus

Por Langer, Rupert, Feith, Marcus, Siewert, Joerg Rüdiger, Wester, Hans-Juergen, Hoefler, Heinz
Publicado em 2008

Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus

Por Slotta-Huspenina, Julia, Becker, Karl-Friedrich, Feith, Marcus, Walch, Axel, Langer, Rupert
Publicado em 2014

Epstein–Barr Virus in Gastro-Esophageal Adenocarcinomas – Single Center Experiences in the Context of Current Literature

Por Genitsch, Vera, Novotny, Alexander, Seiler, Christian A., Kröll, Dino, Walch, Axel, Langer, Rupert
Publicado no Front Oncol (2015)

Sclerosing angiomatoid nodular transformation of the spleen presenting as a rapidly growing tumour in a patient with rectal cancer

Por Langer, Rupert, Dinges, Julia, Dobritz, Martin, Brauer, Robert B, Perren, Aurel, Becker, Karen, Kremer, Marcus
Publicado em 2009

High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma

Por Rauser, Sandra, Langer, Rupert, Tschernitz, Sebastian, Gais, Peter, Jütting, Uta, Feith, Marcus, Höfler, Heinz, Walch, Axel
Publicado em 2010

Expression Profiling of Stem Cell-Related Genes in Neoadjuvant-Treated Gastric Cancer: A NOTCH2, GSK3B and β-catenin Gene Signature Predicts Survival

Por Bauer, Lukas, Langer, Rupert, Becker, Karen, Hapfelmeier, Alexander, Ott, Katja, Novotny, Alexander, Höfler, Heinz, Keller, Gisela
Publicado em 2012

Association between HSP90 and Her2 in Gastric and Gastroesophageal Carcinomas

Por Berezowska, Sabina, Novotny, Alexander, Bauer, Karina, Feuchtinger, Annette, Slotta-Huspenina, Julia, Becker, Karen, Langer, Rupert, Walch, Axel
Publicado em 2013

Discovery of New Molecular Subtypes in Oesophageal Adenocarcinoma

Por Berg, Daniela, Wolff, Claudia, Langer, Rupert, Schuster, Tibor, Feith, Marcus, Slotta-Huspenina, Julia, Malinowsky, Katharina, Becker, Karl-Friedrich
Publicado em 2011

Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas

Por Adams, Olivia, Dislich, Bastian, Berezowska, Sabina, Schläfli, Anna M., Seiler, Christian A., Kröll, Dino, Tschan, Mario P., Langer, Rupert
Publicado no Oncotarget (2016)

Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study

Por Bauer, Lukas, Takacs, Agnes, Slotta-Huspenina, Julia, Langer, Rupert, Becker, Karen, Novotny, Alexander, Ott, Katja, Walch, Axel, Hapfelmeier, Alexander, Keller, Gisela
Publicado no Front Oncol (2015)

CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity

Por Straub, Melanie, Drecoll, Enken, Pfarr, Nicole, Weichert, Wilko, Langer, Rupert, Hapfelmeier, Alexander, Götz, Carolin, Wolff, Klaus-Dietrich, Kolk, Andreas, Specht, Katja
Publicado no Oncotarget (2016)

A retrospective comparative exploratory study on two Methylentetrahydrofolate Reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an indepen...

Por Blank, Susanne, Rachakonda, Sivaramakrishna, Keller, Gisela, Weichert, Wilko, Lordick, Florian, Langer, Rupert, Springfeld, Christoph, Bruckner, Thomas, Becker, Karen, Kumar, Rajiv, Ott, Katja
Publicado em 2014

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy

Por Aichler, Michaela, Motschmann, Martin, Jütting, Uta, Luber, Birgit, Becker, Karen, Ott, Katja, Lordick, Florian, Langer, Rupert, Feith, Marcus, Siewert, Jörg Rüdiger, Walch, Axel
Publicado em 2014

Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer

Por Schläfli, Anna M., Adams, Olivia, Galván, José A., Gugger, Mathias, Savic, Spasenija, Bubendorf, Lukas, Schmid, Ralph A., Becker, Karl-Friedrich, Tschan, Mario P., Langer, Rupert, Berezowska, Sabina
Publicado no Oncotarget (2016)

Evidence of Prognostic Relevant Expression Profiles of Heat-Shock Proteins and Glucose-Regulated Proteins in Oesophageal Adenocarcinomas

Por Slotta-Huspenina, Julia, Berg, Daniela, Bauer, Karina, Wolff, Claudia, Malinowsky, Katharina, Bauer, Lukas, Drecoll, Enken, Bettstetter, Marcus, Feith, Marcus, Walch, Axel, Höfler, Heinz, Becker, Karl-Friedrich, Langer, Rupert
Publicado em 2012

The role of the pathologist in tissue banking: European Consensus Expert Group Report

Por Bevilacqua, Generoso, Bosman, Fred, Dassesse, Thibaut, Höfler, Heinz, Janin, Anne, Langer, Rupert, Larsimont, Denis, Morente, Manuel M., Riegman, Peter, Schirmacher, Peter, Stanta, Giorgio, Zatloukal, Kurt, Caboux, Elodie, Hainaut, Pierre
Publicado em 2010

Histological Assessment of PAXgene Tissue Fixation and Stabilization Reagents

Por Kap, Marcel, Smedts, Frank, Oosterhuis, Wolter, Winther, Rosa, Christensen, Nanna, Reischauer, Bilge, Viertler, Christian, Groelz, Daniel, Becker, Karl-Friedrich, Zatloukal, Kurt, Langer, Rupert, Slotta-Huspenina, Julia, Bodo, Koppany, de Jong, Bas, Oelmuller, Uwe, Riegman, Peter
Publicado em 2011

Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of...

Por Luber, Birgit, Deplazes, Joëlle, Keller, Gisela, Walch, Axel, Rauser, Sandra, Eichmann, Martin, Langer, Rupert, Höfler, Heinz, Hegewisch-Becker, Susanna, Folprecht, Gunnar, Wöll, Ewald, Decker, Thomas, Endlicher, Esther, Lorenzen, Sylvie, Fend, Falko, Peschel, Christian, Lordick, Florian
Publicado em 2011